Gilead Sciences reported $12.63B in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Abbvie ABBV:US $ 26509M 1419M
Acorda Therapeutics ACOR:US $ 80.46M 21.7M
Agios Pharmaceuticals AGIO:US $ 975.14M 89.09M
ALKERMES ALKS:US 1.01B 47.34M
Alnylam Pharmaceuticals ALNY:US $ 2589.68M 218.9M
Amgen AMGN:US $ 18520M 865M
Biogen BIIB:US $ 7915.9M 59.4M
Biomarin Pharmaceutical BMRN:US $ 2394.02M 119.64M
Bluebird Bio BLUE:US $ 254.92M 81.6M
Bristol Myers Squibb BMY:US $ 30121M 3141M
Coherus Biosciences CHRS:US $ 512.44M 89.88M
Eli Lilly And LLY:US $ 16964.7M 1487.7M
Gilead Sciences GILD:US $ 12629M 2143M
GlaxoSmithKline GSK:LN 28.99B 10.31B
Glaxosmithkline GSK:US $ 28988M 10314M
Intercept Pharmaceuticals ICPT:US $ 477.35M 24.94M
Johnson & Johnson JNJ:US $ 60424M 555M
Merk MRK:US $ 31184M 918M
Moderna Inc MRNA:US 16.35B 279M
Neurocrine Biosciences NBIX:US $ 1018.2M 45.4M
Novartis NOVN:VX 37.24B 8.48B
Pfizer PFE:US $ 54420M 5273M
Ptc Therapeutics PTCT:US $ 774.01M 180.36M
Puma Biotechnology PBYI:US $ 117.57M 22.45M
Regeneron Pharmaceuticals REGN:US $ 14306M 291.1M
Sangamo Biosciences SGMO:US $ 340.06M 58.7M
Sarepta Therapeutics SRPT:US $ 2530.95M 73.15M
Teva Pharmaceutical Industries TEVA:US $ 12451M 122M
United Therapeutics UTHR:US $ 2586.6M 263M
Vertex Pharmaceuticals VRTX:US $ 10361.3M 800.7M
YTE INCY:US $ 3288.09M 169.42M